Expertise
Dr. Smith’s expertise in the assessment of human health risk includes the following agents:
- Hazardous Metals
- Arsenic, Barium, Beryllium, Cadmium, Calcium, Chromium, Copper, Lead, Magnesium, Manganese, Mercury, Silver, Selenium, Thallium, Zinc
- Petroleum Products
- Specialty Oils & Solvents
- Manufactured Gas Plant Wastes
- Fractions/Components
- Polycyclic Aromatic Hydrocarbons (PAH)
- Volatile Petroleum Hydrocarbons (VPH)
- Extractable Petroleum Hydrocarbons (EPH)
- Volatile Organic Compounds (VOC)
- Chlorinated Solvents
- Non-Chlorinated Organic Compounds
- Persistent Polyhalogenated Organic Compounds
- Polychlorinated Dibenzo-p-dioxin (PCDD)
- Polychlorinated Dibenzofuran (PCDF)
- Polychlorinated Biphenyls (PCBs)
- Pesticides
- Silica (crystalline and Amorphous)
- Particulate
and the following techniques;
- Product/Method Evaluation
- Exposure Assessment
- Derivation of Toxicity Values
- Modeling Receptor Exposure
- Validation of Machine/Methodology
- Confidential Evaluation of New Products
- Study Design
- Sampling and Analysis
- Soils/Sediments
- Air (particulate/volatiles)
- Groundwater/Surface Water
- Surfaces (PCBs, Mercury, Lead)
- Use of Surrogate Toxicity Values
- Congener-Specific Analyses (Dioxins/PCBs)
- Assessment of Relative Bioaccessibility/Bioavailability
- PAH Source Determination (Methyl Aromatic Ratio Analysis)
- Derivation of Site-Specific Alternative Remedial Goals
- Soils/sediments, Groundwater, Surface Water, Indoor air
- Techniques Applicable to Hazardous Metals
- Free vs. Bound
- Fate, Transport, & Disposition
- Relative Bioaccessibility/Bioavailability
- U.S. EPA Lead Models
- Techniques Applicable to PAH Compounds
- Estimated Order of Potency (EOP) Approach
- Massachusetts VPH/EPH Approach
- PAH Source Determination (Methyl Aromatic Ratio Analysis)
- Techniques Applicable to Volatile Organic Compounds
- Modeling Vapor Intrusion of Indoor Air
- Techniques Applicable to Persistent Polyhalogenated Organic Compounds
- U.S. EPA Toxic Equivalency Factor (TEF) Approach
- Mixture and Congener-Specific Evaluation of Risk
- Evaluation and Use of Biomarkers of Exposure & Harm
- Comparison of Relative Risk